GANYMEDE vs GANYMEDE
| GANYMEDE | GANYMEDE | Difference | |
|---|---|---|---|
| GPU Score | 57965 | 57965 | 100.0% |
| GANYMEDE | |||
| GANYMEDE | |||
| Geekbench 5.3.1 Tryout | Geekbench 5.3.1 Tryout | ||
System Information
| GANYMEDE | GANYMEDE | |
|---|---|---|
| Operating System | Microsoft Windows 10 Home (64-bit) | Microsoft Windows 10 Home (64-bit) |
| Model | System manufacturer System Product Name | System manufacturer System Product Name |
| Processor |
Intel Core i5-9400F @ 2.89 GHz
1 Processor, 6 Cores |
Intel Core i5-9400F @ 2.89 GHz
1 Processor, 6 Cores |
| Motherboard | ASUSTeK COMPUTER INC. PRIME H310M-K | ASUSTeK COMPUTER INC. PRIME H310M-K |
| Memory | 16.00 GB DDR4 SDRAM | 16.00 GB DDR4 SDRAM |
| OpenCL Information | ||
| Platform Vendor | NVIDIA Corporation | NVIDIA Corporation |
| Platform Name | NVIDIA CUDA | NVIDIA CUDA |
| Device Vendor | NVIDIA Corporation | NVIDIA Corporation |
| Device Name | GeForce GTX 1660 | GeForce GTX 1660 |
| Board Name | ||
| Compute Units | 22 | 22 |
| Maximum Frequency | 1.81 GHz | 1.81 GHz |
| Device Memory | 6.00 GB | 6.00 GB |
GPU Performance
| GANYMEDE | GANYMEDE | Difference | |
|---|---|---|---|
| GPU Score | 57965 | 57965 | 100.0% |
| GANYMEDE | |||
| GANYMEDE | |||
| Sobel | 62879 | 62879 | 100.0% |
| GANYMEDE | |||
| GANYMEDE | |||
| Canny | 39461 | 39461 | 100.0% |
| GANYMEDE | |||
| GANYMEDE | |||
| Stereo Matching | 221919 | 221919 | 100.0% |
| GANYMEDE | |||
| GANYMEDE | |||
| Histogram Equalization | 40910 | 40910 | 100.0% |
| GANYMEDE | |||
| GANYMEDE | |||
| Gaussian Blur | 43678 | 43678 | 100.0% |
| GANYMEDE | |||
| GANYMEDE | |||
| Depth of Field | 106659 | 106659 | 100.0% |
| GANYMEDE | |||
| GANYMEDE | |||
| Face Detection | 19119 | 19119 | 100.0% |
| GANYMEDE | |||
| GANYMEDE | |||
| Horizon Detection | 54743 | 54743 | 100.0% |
| GANYMEDE | |||
| GANYMEDE | |||
| Feature Matching | 27134 | 27134 | 100.0% |
| GANYMEDE | |||
| GANYMEDE | |||
| Particle Physics | 293422 | 293422 | 100.0% |
| GANYMEDE | |||
| GANYMEDE | |||
| SFFT | 28385 | 28385 | 100.0% |
| GANYMEDE | |||
| GANYMEDE | |||
